U2OS cells express hardly detectable amounts of Spry1, while the Spry3 amounts are more pronounced than in the most other osteosarcoma-derived cell lines, but about five times less than in SAOS2 cells. This evidence concerns the gene SPRY3 and osteosarcoma.